Molson Coors secures Fever-Tree’s U.S. rights

Molson Coors expands its U.S. non-alcoholic portfolio with a new strategic partnership with Fevertree Drinks plc.

Starting February 1, 2025, Molson Coors will assume exclusive commercialization rights to Fever-Tree’s tonics, ginger beers, cocktail mixers, etc. in the U.S. and will be responsible for co-manufactured production, marketing, sales and distribution of the brand in the U.S.

“Our strategic partnership with Fever-Tree in the U.S. is a meaningful step in Molson Coors’ journey to becoming a total beverage company with a winning portfolio of drinks for a wide variety of consumer occasions. We’ve made progress here, and today we are building on that progress in a significant way with Fever-Tree as the latest and largest non-alcoholic brand to join our portfolio,” said Molson Coors’ CEO Gavin Hattersley.

The company is also acquiring an 8.5 per cent stake in Fevertree Drinks plc, which makes Molson Coors Fevertree’s second largest shareholder.

“Today’s announcement marks a transformational step for the Fever-Tree brand in the US and is not only a reflection of how far we have come since first entering the market in 2008, but also how the opportunity ahead for the brand continues to grow,” said Fever-Tree CEO Tim Warrillow. “With a national network providing scale and muscle, proven track record, supply chain expertise and clearly stated strategic desire to drive the future of their business beyond beer, Molson Coors are the ideal partner to take the Fever-Tree brand to the next level across the U.S.”

The partnership with Fever-Tree builds on Molson Coors’ plan to go beyond beer. The company took a majority stake in ZOA Energy in November 2024. It is also is preparing to bring Naked Life, a leading Australian non-alcoholic RTD cocktail brand to the U.S. this spring.